Heart & Kidney Health Screening Available for Free in Seattle, Jan 22-24 Care Access, a health and research company, is offering its Heart & Kidney Health Screening initiative to residents…
Breast Cancer: DATROWAY® Approved in U.S. for Metastatic HR Positive, HER2 Negative Type DATROWAY® (datopotamab deruxtecan-dlnk), an innovative TROP2-directed antibody-drug conjugate (ADC), has been approved by the U.S. Food and…
Announces TripleBlind Exchange: Selfii’s Secure HIPAA-Compliant Health Data Access Selfii, a leader in privacy-preserving health data solutions for individuals and healthcare organizations, announces the launch of its groundbreaking data marketplace,…
Agreement Between Neuraly and Enigma Biomedical USA on PET Imaging Biomarker PMI04 On January 16, 2025, Neuraly Inc., a wholly owned subsidiary of D&D Pharmatech Inc., and Enigma Biomedical USA,…
Cell Therapy Platform Enhanced: Charles River and Akron Bio Integrate CGMP Materials Charles River Laboratories International, Inc. (NYSE: CRL) and Akron Bio, a leading supplier of critical materials and services…
Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions for the life sciences industry, has announced new appointments to its leadership team. Alicia Staley has been named…
Zai Lab Reports Positive TIVDAK Results in China for Cervical Cancer Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) has announced positive topline results from the China subpopulation of the global…
Hologic Reports Preliminary Revenue Results for Q1 Fiscal 2025 Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health and diagnostic solutions, today announced its preliminary revenue results for the…
Reports Positive Results from SP-624 qEEG and BNA™ Study by Arrivo BioVentures Arrivo BioVentures recently reported promising results from its SP-624-103 study, which evaluated the impact of SP-624’s novel epigenetic…
QIAGEN Enhances QIAcuity with Advanced Multiplexing Function QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) has announced a major enhancement to its QIAcuity digital PCR (dPCR) system, significantly boosting its performance.…
Colorectal Cancer: SOTIO Advances SOT109 ADC and Licenses Antibodies from Biocytogen SOTIO Biotech, a clinical-stage biopharmaceutical company owned by the PPF Group, has announced an exciting milestone in the development…
Cyrus Selects CYR212 as Candidate for IgG-Driven Autoimmune Diseases Cyrus Biotechnology, an AI-driven therapeutics company, announced the selection of CYR212 as its clinical development candidate for chronic IgG-driven autoimmune diseases.…